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Peroxisomes have long been established to play
a central role in regulating various metabolic activi-
ties in mammalian cells. These organelles act in con-
cert with mitochondria to control the metabolism of
lipids and reactive oxygen species. However, while
mitochondria have emerged as an important site of
antiviral signal transduction, a role for peroxisomes
in immune defense is unknown. Here, we report
that the RIG-I-like receptor (RLR) adaptor protein
MAVS is located on peroxisomes and mitochondria.
We find that peroxisomal and mitochondrial MAVS
act sequentially to create an antiviral cellular state.
Upon viral infection, peroxisomal MAVS induces the
rapid interferon-independent expression of defense
factors that provide short-term protection, whereas
mitochondrial MAVS activates an interferon-depen-
dent signaling pathway with delayed kinetics, which
amplifies and stabilizes the antiviral response. The
interferon regulatory factor IRF1 plays a crucial role
in regulating MAVS-dependent signaling from perox-
isomes. These results establish that peroxisomes
are an important site of antiviral signal transduction.
INTRODUCTION
A fundamental feature of eukaryotic cells is the use of mem-
brane-bound organelles to compartmentalize activities and
serve as scaffolds for signal transduction. The best-character-
ized signaling pathways involve membrane-bound receptors
that respond to extracellular or lumenal stimuli. In these
instances, the spatial separation of an extracellular stimulus
from the cytosol mandates the use of organelles as signaling
platforms, as transmembrane receptors must transmit informa-668 Cell 141, 668–681, May 14, 2010 ª2010 Elsevier Inc.tion across a lipid bilayer. However, an important gap exists in
our knowledge of how stimuli from the cytosol are able to initiate
specific signaling events.
How common is the use of organelles in signal transduction
from cytosolic receptors? An example of this situation can be
found in the study of virus-host interactions. The ability to detect
cytosolic viruses depends on the RIG-I-like receptor (RLR) family
of proteins, which are soluble RNA helicases that detect viruses
containing RNA (and in some cases DNA) genomes (Ablasser
et al., 2009; Chiu et al., 2009; Yoneyama et al., 2004). The best
characterized RLRs, RIG-I and MDA-5, detect 50-triphosphate-
containing short double-stranded RNA (dsRNA) and long dsRNA,
respectively (Kato et al., 2008; Pichlmair et al., 2006). RLRs can
either detect viral RNA directly or after RNA polymerase III-medi-
ated transcription of microbial DNA (Ablasser et al., 2009; Chiu
et al., 2009; Kato et al., 2008). Mice deficient in either of these
RLRs are sensitive to different classes of viruses, underscoring
both their specificity of action and their importance in immune
defense (Gitlin et al., 2006; Kato et al., 2006).
Although RIG-I and MDA-5 have specificities for different
ligands, both induce a common signaling pathway that triggers
the expression of type I interferons (IFNs) and IFN-stimulated
genes (ISGs). Many ISGs function as direct antiviral effec-
tors, acting to prevent viral genome replication, viral particle
assembly, or virion release from infected cells. Generally, it is
thought that RLRs induce the expression of IFNs that act in
both autocrine and paracrine manners to amplify ISG expres-
sion. However, ISGs can also be induced directly upon viral
infection, without the need for IFN signaling (Collins et al.,
2004; Mossman et al., 2001). At the receptor-proximal level,
RLR-dependent responses are regulated by the adaptor pro-
tein MAVS (also called IPS-1, Cardif, or VISA) (Nakhaei et al.,
2009). Upon viral detection, MAVS binds to RLRs and promotes
the activation of NF-kB, AP-1, and various interferon regulatory
factors (IRFs), which act to induce ISGs and create an antiviral
state in the cell. Although much has been learned about the
genetics of RLR signaling, less is known about where within
the cell signal transduction occurs. Identifying the sites of RLR
signal transduction is critical to understanding how antiviral
networks are integrated into the general cellular infrastructure
within which they operate.
The first clue that cytosolic RLR signaling may occur from
organelles came from studies of the MAVS adaptor. MAVS
contains a C-terminal transmembrane domain that anchors it
to the mitochondrial outer membrane (Seth et al., 2005). It is
from this location that MAVS is thought to engage active RLRs
and induce signal transduction. Whether mitochondria are the
only organelles that promote RLR-mediated signaling has not
been addressed.
Mitochondria have long been appreciated to have an intimate
functional relationship with peroxisomes (Hettema and Motley,
2009). Both are membrane-bound organelles found in mammalian
cells and are involved in the metabolism of lipids and reactive
oxygenspecies. However, while mitochondriaare well-established
sites of both antiviral signaling and antiviral apoptosis, peroxi-
somes are thought to function solely as metabolic organelles.
Recently, several mitochondrial proteins have been found to
reside also on peroxisomes. Included in this group are the outer
membrane proteins Fis1 and Mff, which regulate the morphology
of both organelles (Gandre-Babbe and van der Bliek, 2008; Koch
et al., 2005). Interestingly, Fis1, Mff, and MAVS all have similar
domain structures: each contains an N-terminal effector domain
and a C-terminal localization motif, which consists of a trans-
membrane domain and a short lumenal tail containing basic
amino acids. That other so-called ‘‘tail-anchored’’ mitochondrial
outer membrane proteins operate from peroxisomes raised the
possibility that MAVS also functions from these organelles.
We have discovered that MAVS does indeed reside on perox-
isomes and can induce antiviral signaling from this organelle.
Our work supports a model whereby peroxisomal MAVS induces
the immediate expression of antiviral factors that function to
contain a nascent infection. Long-term containment of the infec-
tion, however, requires the function of mitochondrial MAVS as
well. These data demonstrate that peroxisomes are not simply
metabolic organelles, but rather serve as critical subcellular
hubs that promote MAVS-dependent antiviral immunity.
RESULTS
MAVS Is Located on Both Mitochondria
and Peroxisomes
MAVS has a similar domain organization to other tail-anchored
membrane proteins that function from mitochondria and perox-
isomes (Gandre-Babbe and van der Bliek, 2008; Koch et al.,
2005). We therefore sought to determine whether MAVS also
resides on peroxisomes. The subcellular localization of MAVS
was examined in mouse embryonic fibroblasts (MEFs) whose
peroxisomes were marked by a DsRed allele containing a type
1 peroxisomal targeting signal (PTS1). In addition to staining
structures that appeared to be mitochondria, MAVS was
detected on PTS1-positive peroxisomes scattered throughout
the cell (Figure 1A). A similar staining pattern was seen for Mff
(Figure 1A), which functions from both peroxisomes and mito-
chondria (Gandre-Babbe and van der Bliek, 2008). In contrast,
the Toll-like receptor (TLR) adaptor protein TIRAP (Fitzgeraldet al., 2001; Horng et al., 2001) was not detected on peroxisomes
(Figure 1A). To confirm that the peroxisomal staining was dis-
tinct from mitochondria, we also stained cells with MitoTracker.
Although no costaining was detected between PTS1 and Mito-
Tracker, MAVS was detected on both PTS1-positive peroxi-
somes and MitoTracker-positive mitochondria (Figure 1B). Sim-
ilar results were obtained when epitope-tagged MAVS in murine
macrophages (Figure S1 available online) or endogenous MAVS
in human hepatocytes were examined (Figure 1C). As an inde-
pendent means of assessing MAVS localization, hepatocytes
were biochemically fractionated to separate peroxisomes and
mitochondria, which were respectively distinguished by Pex14
and mtHSP70 (Figure 1D). Both MAVS and Fis1 (a protein that
occupies both organelles [Koch et al., 2005]) were detected in
fractions containing either peroxisomes or mitochondria. Collec-
tively, on the basis of studies in both human and mouse cells,
these data establish that peroxisomes are a bona fide reservoir
of the RLR adaptor protein MAVS.
One possible reason MAVS is present on peroxisomes is that
newly synthesized MAVS might first pass through peroxisomes
en route to mitochondria. To address this possibility, we used
human fibroblasts from a patient lacking a functional Pex19
protein. Pex19 controls peroxisome biogenesis, and thus Pex19-
deficient cells contain no peroxisomes or peroxisomal remnant
structures (Matsuzono et al., 1999; Sacksteder et al., 2000).
Notably, MAVS was delivered to mitochondria in Pex19-deficient
cells (Figure 1E), indicating that the pathway to mitochondria
does not require a peroxisomal intermediate. Moreover, MAVS
localized to both peroxisomes and mitochondria in Pex19-defi-
cient cells that expressed Pex19 after transient transfection or
retroviral gene transfer (Figure 1E). It is therefore unlikely that
localization of MAVS to peroxisomes is the result of a biosynthetic
pathway for delivering outer membrane proteins to mitochondria.
A Systematic Strategy to Separate Functions
of Peroxisomal and Mitochondrial MAVS
Our finding that MAVS is located on peroxisomes raised the
possibility that these organelles serve as a site of antiviral signal
transduction. We first considered using Pex19-deficient cells
to address sufficiency of mitochondrial MAVS in antiviral sig-
naling, but since peroxisomes are required for biochemical pro-
cesses that occur in mitochondria, Pex19-deficient cells have
profound defects in mitochondrial function (Wanders, 2004).
We therefore used the alternative approach of genetically sepa-
rating the putative mitochondrial and peroxisomal functions of
MAVS. This was accomplished by replacing the previously
defined MAVS localization motif (Seth et al., 2005) with a set of
domains that instead direct the protein to a single compartment
(Figure 2A). Using the localization motif of the peroxin Pex13
(Fransen et al., 2001), we created a protein called MAVS-Pex.
By deleting the MAVS localization motif, we also created a cyto-
solic allele (MAVS-Cyto) (Seth et al., 2005). Because the fidelity
of mitochondrial sorting signals is not always transferrable to
other proteins (Ingelmo-Torres et al., 2009), we lastly created
two different alleles of MAVS containing a sorting signal derived
from two proteins residing on the mitochondrial outer membrane
protein, either OMP25 or Fis1 (Koch et al., 2005; Nemoto and
De Camilli, 1999).Cell 141, 668–681, May 14, 2010 ª2010 Elsevier Inc. 669
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Figure 1. MAVS resides on mitochondria and peroxisomes
(A) MEFs were transfected with the peroxisomal marker DsRed-PTS1 and Flag-MAVS, myc-MFF, or Flag-TIRAP. Cells were stained with anti-MAVS, anti-myc, or
anti-Flag antibodies, respectively. All images for all panels are representative of at least three independent experiments in which over 500 cells were examined per
condition and >95% of the cells displayed similar staining.
(B) MEFs expressing Flag-MAVS as well as EGFP-PTS1 and Pex19 from a bicistronic construct were stained with anti-MAVS antibody and MitoTracker to visu-
alize mitochondria.
(C) Huh-7 hepatocytes were transfected with DsRed-PTS1 and endogenous MAVS was detected with anti-MAVS antisera.
(D) Peroxisomes were separated from mitochondria on a Nycodenz gradient with HepG2 hepatocyte lysates. Selected fractions of the gradient were analyzed by
immunoblotting with Pex14, mtHSP70, Fis1, or MAVS antisera.
(E) Pex19-deficient human fibroblasts were stained for endogenous MAVS before and after introduction of a functional Pex19 allele as indicated. Mitochondria
were stained with anti-mtHSP70 antibody. Peroxisomes were visualized by transfection with a bicistronic construct encoding EGFP-PTS1 and Pex19.
See also Figure S1.Using retroviral gene transfer of MAVS-KO MEFs, we created
cell lines expressing comparable levels of each MAVS allele
(Figures 2B and 2C) and determined their localizations by con-670 Cell 141, 668–681, May 14, 2010 ª2010 Elsevier Inc.focal microscopy. Full-length MAVS (MAVS-WT) was located
on both mitochondria and peroxisomes (data not shown), and
MAVS-Cyto was found on neither organelle (Figure 2D and
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Figure 2. Targeting of MAVS to Distinct
Subcellular Compartments by Replacement
of Its Transmembrane Domain
(A) Schematic of WT and mutant MAVS alleles to
be tested for signaling from peroxisomes and
mitochondria.
(B) Stable cell lines expressing the MAVS alleles
listed in (A) were generated by retroviral transduc-
tion of MAVS-KO cells. Resulting transgenic cells
expressed a MAVS allele and GFP, whose transla-
tion is directed by an IRES. Shown are overlaid
histograms of stable populations of each cell line
expressing equivalent levels of the bicistronic
mRNAs encoding MAVS and GFP.
(C) Lysates from stable cell lines described in (B)
and parental MAVS KO MEFs were analyzed by
immunoblotting with anti-MAVS antibody.
(D) Micrographs of MAVS chimeric cell lines indi-
cated were stained with anti-MAVS antibody.
Mitochondria were stained with anti-mtHSP70
antibody. Peroxisomes were visualized by trans-
fection with DsRed-PTS1. Note that MAVS-Pex
resides on peroxisomes, MAVS-Mito on mito-
chondria, MAVS-Mimic on both organelles, and
MAVS-Cyto localizes on neither of the two organ-
elles. All images for all panels are representative
of at least three independent experiments where
over 500 cells were examined per condition and
>95% of the cells displayed similar staining.
See also Figure S2.Figure S2). As expected, MAVS-Pex was found exclusively on
peroxisomes (Figure 2D and Figure S2). Of the alleles contain-
ing the putative mitochondrial targeting sequences, the allele
harboring the Fis1 transmembrane domain was found primarily
on mitochondria, whereas the one containing the OMP25
transmembrane domain was located on both mitochondria and
peroxisomes (Figure 2D and Figure S2). We therefore refer to the
mitochondria-specific allele as MAVS-Mito to indicate its exclu-
sive localization to mitochondria and the allele found on both
organelles as MAVS-Mimic to indicate its ability to copy the
localization pattern of MAVS-WT. Collectively, this set of
MAVS-expressing MEF lines differs only in the subcellular posi-
tioning of the signaling domain of MAVS and thereby provides
an ideal system to determine the relative roles of mitochondrial
and peroxisomal localization in MAVS-dependent signal
transduction.
MAVS-Dependent Signaling Occurs from Both
Peroxisomes and Mitochondria
To address the function of peroxisomal MAVS, we monitored the
expression of antiviral factors in response to infection with
reovirus. We chose reovirus because it is a known inducer ofCell 141, 668–both RIG-I and MDA-5 signaling path-
ways (Loo et al., 2008), allowing direct
examination of both RLRs in a single
experiment.
Cells were infected with reovirus, and
extracts were examined at various times
for expression of viperin, a well-charac-terized ISG (Chin and Cresswell, 2001; Severa et al., 2006).
MAVS-WT-, -Mimic-, or -Mito-expressing cells induced viperin
expression in response to infection (Figure 3A). This response
was MAVS dependent, as MAVS-KO cells showed no change in
viperin expression. MAVS-Cyto cells were unable to induce vi-
perin expression, confirming that membrane localization is neces-
sary for MAVS function (Seth et al., 2005). Interestingly, despite
the fact that MAVS-Pex is found only on peroxisomes, MAVS-
Pex cells induced viperin expression after infection (Figure 3A).
An examination of the kinetics of ISG induction indicated
that cells containing MAVS on peroxisomes (MAVS-WT, -Mimic,
and -Pex) induced viperin expression within 4 hr of infection.
In contrast, exclusive localization to mitochondria (MAVS-Mito)
resulted in viperin expression with delayed kinetics (Figure 3A).
These results suggest that localization of MAVS to either perox-
isomes or mitochondria is sufficient to induce antiviral signaling
but that peroxisomal residence allows for more rapid expression
of ISGs. Interestingly, rapid expression of ISGs by MAVS-Pex
appeared to be transient, as viperin expression decreased at
later times of infection (Figure 3A).
To determine whether peroxisomal signaling by MAVS
requires signaling by both RIG-I and MDA-5, we performed681, May 14, 2010 ª2010 Elsevier Inc. 671
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Figure 3. Peroxisomal MAVS Mediates ISG
Expression, but Does Not Induce Type I IFN
Secretion
(A) MAVS-expressing MEFs and MAVS-KO cells
were infected with reovirus. At indicated times,
cell-associated ISG expression was determined by
immunoblotting with an anti-viperin antibody.
(B) Similar to (A) except for infection with influenza
virus strain DNS1 in lieu of reovirus.
(C and D) Cell culture media from (A) and (B) were
tested for type I IFN activity using a bioassay. Error
bars show the standard deviation of triplicate infec-
tions.
(E) MAVS-expressing MEFs and parental MAVS-KO
cells were treated with 100 IU/ml IFNb. At indicated
times, cell-associated ISG expression was deter-
mined by immunoblotting with anti-viperin anti-
body. Note that all cell lines respond similarly to
IFNb, indicating intact type I IFN signaling.
All data are the result of at least two independent
experiments. See also Figure S3.similar experiments using influenza virus, which activates the
RIG-I pathway exclusively (Gitlin et al., 2006; Kato et al., 2006).
A similar pattern of viperin expression was observed with influ-
enza as with reovirus, although the kinetic differences between
MAVS-Pex and -Mito were even more pronounced with influenza
(Figure 3B). Thus, RIG-I signaling alone is sufficient to induce
MAVS-dependent signaling from peroxisomes. In sum, these
data indicate that peroxisomal MAVS induces rapid but tran-
sient viperin expression, whereas mitochondrial MAVS induces
delayed but stable viperin expression. Signaling from both
organelles thus contributes to the rapid and stable expression
of viperin that is observed in MAVS-WT cells.
While the above studies provide strong genetic evidence for
MAVS signaling from peroxisomes in a population of cells,
they do not allow us to examine individual cells for compart-
ment-specific signaling events. To address this, we took advan-
tage of the fact that various signaling pathways induce morpho-
logical changes in the organelles where signaling occurs,
including RLR-dependent activities on mitochondria (Castanier
et al., 2010; Yasukawa et al., 2009). We reasoned that if
signaling was actually occurring on these organelles, then their
morphology may change during viral infection. In support of this672 Cell 141, 668–681, May 14, 2010 ª2010 Elsevier Inc.prediction, reovirus infection induced
peroxisomal aggregation and the forma-
tion of peroxisomal tubules (Figures S3A
and S3B). The tubes formed ranged from
approximately 2 mm in length to over 5
mm and depended on MAVS localization
to peroxisomes. Cells expressing MAVS-
WT exhibited this activity, and cells ex-
pressing MAVS-Pex have greatly exagger-
ated behavior in these assays, with nearly
all cells displaying peroxisomes over 5
mm in length (Figures S3A and S3B). Cells
expressing MAVS-Mito or MAVS-Cyto ex-
hibited little or no change in peroxisomemorphology. These data suggest that RLRs engage peroxi-
somal MAVS to induce peroxisomal tubules and that the extent
of tubulation is determined by the concentration of MAVS on
these organelles. These independent assays demonstrate that
MAVS-dependent signaling occurs locally (on the peroxisome).
Peroxisomal MAVS Triggers an IFN-Independent
Signaling Pathway that Promotes ISG Expression
The different kinetics of viperin induction by peroxisomal and
mitochondrial MAVS suggest that more than one mechanism
of RLR-induced ISG expression may operate in virus-infected
cells. ISG expression can be induced directly, or it can be
induced indirectly through the action of secreted type I IFNs
(Collins et al., 2004; Mossman et al., 2001). To determine
whether IFNs contribute to expression of ISGs induced by mito-
chondrial or peroxisomal MAVS, we monitored the rate of IFN
production by reovirus-infected cells. As expected, IFN produc-
tion was dependent on membrane-localized MAVS, and all
mitochondrial MAVS proteins (MAVS-WT, -Mimic, and -Mito)
triggered IFN production, though with delayed kinetics in the
case of MAVS-Mito (Figure 3C). These data indicate that in the
case of the mitochondria-localized MAVS proteins, IFN
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Figure 4. Peroxisomal MAVS Directly Induces Viperin Expression
(A) MAVS-expressing MEFs and MAVS-KO cells were pretreated with 20 mg/ml BFA before infection with reovirus in presence of the drug. At indicated times, cell
supernatants were tested for type I IFN activity via a bioassay.
(B) Similar to (A) except type I IFN activity was blocked by addition of 250 NU/ml anti-IFNb and 500 NU/ml anti-IFNa antibodies after infection with reovirus.
(C and D) Cell lysates from (A) and (B) were tested for ISG expression by immunoblotting with anti-viperin antibody. Note that IFN activity is not required for viperin
expression mediated by peroxisomal MAVS.
All data are the representative of at least three independent experiments. Error bars show standard deviation of triplicate infections.expression coincides with ISG induction. Surprisingly, no detect-
able IFNs were produced by MAVS-Pex cells. Similar results
were obtained with cells infected with influenza virus
(Figure 3D), though the relative amounts of IFNs produced with
these two viruses differed dramatically, reflecting unique
aspects of each virus life cycle. However, our inability to detect
a role for IFNs in promoting viperin expression in MAVS-Pex cells
was not due to an inability of the cells to respond to IFNs,
because addition of recombinant IFNb was sufficient to induce
viperin expression in all cells examined (Figure 3E).
The observation that viperin can be expressed in the absence
of type I IFN induction suggests that IFNs may not contribute to
ISG expression induced by peroxisomal MAVS. We tested this
possibility by infecting cells under conditions in which the func-
tions of IFNs are prevented, by either disrupting protein secre-
tion with brefeldin A (BFA) or by utilizing neutralizing antibodies
against secreted IFNs. Both treatments disrupted the activity of
type I IFNs produced during reovirus infection (Figures 4A and
4B) and inhibited the expression of viperin by cells expressing
mitochondrial MAVS (MAVS-WT, -Mimic, and -Mito) (Figures
4C and 4D). These data indicate that signaling by IFNs promotes
viperin expression. However, because these treatments did not
completely abolish viperin expression, an IFN-independent
pathway of viperin induction must also exist. Interestingly, MAVS
signaling from peroxisomes primarily utilized the IFN-indepen-
dent pathway, as viperin expression within MAVS-Pex cellswas largely resistant to these treatments (Figures 4C and 4D).
These data therefore indicate that the subcellular positioning
of MAVS determines the type of signaling pathway activated
during viral infection. Peroxisomal MAVS induces the rapid
and direct expression of viperin, which is followed by mitochon-
drial MAVS triggering viperin expression directly, as well as indi-
rectly through the IFN-mediated feed-forward loop.
The Global Transcriptional Response to Reovirus
Infection Is Mediated by the Collective Actions
of MAVS-Dependent Peroxisomal
and Mitochondrial Signaling
Based on the set of candidate genes examined, our data sug-
gests that peroxisomal and mitochondrial MAVS each induce
a complementary set of genes that are collectively induced by
MAVS-WT. To determine whether this is the case, microarrays
were performed on reovirus-infected cells. Infections were per-
formed for 3, 9, or 16 hr, and RNA was collected for genome-
wide expression analysis. At all times examined, similar expres-
sion profiles were observed when MAVS-WT and MAVS-Mimic
cells were compared, confirming that similarities in MAVS local-
ization are predictive of similarities in MAVS function (Figures 5A
and 5B). These cells induced the expression of numerous ISGs,
IFNs, and chemokines (Figure 5C). Notably, we were unable to
detect the expression of the proinflammatory cytokines TNFa,
IL-1b, or IL-6 (data not shown). MAVS-Cyto cells were mostCell 141, 668–681, May 14, 2010 ª2010 Elsevier Inc. 673
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similar to MAVS-KO cells (Figures 5A and 5B), further confirming
that membrane localization of MAVS is critical for its function in
antiviral signaling. Interestingly, MAVS-Pex- or -Mito-expressing
cells displayed a transcriptome that each partially overlapped
with that of MAVS-WT cells, but were distinct from one another
(Figures 5B and 5C). For example, at 16 hr after infection,
MAVS-Mito cells upregulated genes encoding chemokines,
ISGs, IFNb, and several IFNa family members (Figures 5B and
5C). MAVS-Pex cells also induced the expression of chemokines
and ISGs, but without any detectable changes in IFN expression
and with much faster kinetics (within 3 hr). Thus, on a global
scale, peroxisomal MAVS induces the rapid expression of ISGs
without inducing IFN expression, whereas mitochondrial MAVS
promotes IFN and ISG expression but with delayed kinetics.
We confirmed these results by examining the expression of
several candidate IFNs and ISGs using nCounter, which allows
for multiplex analysis of gene expression with the sensitivity
of quantitative RT-PCR (Geiss et al., 2008) (Figures S4A and
S4B). Overall, at all times examined, most genes expressed by
either peroxisomal or mitochondrial MAVS were induced by
MAVS-WT or -Mimic (Figures 5B and 5C). These data therefore
support a model whereby the host transcriptional response is
the result of MAVS signaling from both mitochondria and perox-
isomes. We do note however, that the magnitude of antiviral
gene expression induced by cells expressing MAVS-WT or
MAVS-Mimic was greater than the magnitude induced by cells
where MAVS was restricted to a single organelle, which sug-
gests that signaling from both organelles may be coordinated
to ensure maximal antiviral gene expression.
Peroxisomal Signal Transduction Creates a Transient
but Functional Antiviral State
MAVS-dependent signaling promotes an antiviral state, which is
functionally defined as the ability of cells to restrict multiplication
of viruses. To determine the significance of mitochondrial or
peroxisomal signaling pathways in this regard, we asked
whether signaling from either organelle is sufficient to restrict
viral replication. We addressed this by infecting MAVS-express-
ing cells with reovirus and measuring production of infectious
virions over time. As expected, MAVS-WT and -Mimic cells
were most resistant to infection, and MAVS-KO and -Cyto cells
were most susceptible (Figure 6A). These data indicate that
MAVS signaling is required to limit reovirus replication. Interest-
ingly, cells expressing MAVS-Pex or MAVS-Mito exhibited an
unusual biphasic behavior. Over the first 24 hr, these cells
restricted viral replication as well as MAVS-WT, but this capacity
diminished, and by 72 hr were most similar to the MAVS-KOFigure 5. Genome-wide Transcriptome Analysis Reveals a General
Expression
(A) RNA from MAVS-expressing MEFs and parental MAVS-KO cells after infection
of the overall gene expression profiles mediated by the indicated MAVS alleles
clustered along both axes based on their correlation value. Note that at 3 hr after i
to MAVS-WT cells.
(B) Pairwise comparisons of indicated cell lines based on 4089 significantly regu
a gene whose expression level exhibited a change of greater than 2-fold.
(C) Heat map of selected genes based on their expression ratios across all six c
Genes are colored according to a log2-based color bar depicted underneath eacells. These data establish that signaling from either peroxi-
somes or mitochondria is sufficient to induce a functional anti-
viral response, but signaling from both organelles is necessary
for maximal containment of reovirus replication.
Vesicular stomatitis virus (VSV) is one of many viruses that
interfere with type I IFN expression as part of their pathogenic
lifecycle (Figures 6B and 6C) (Ferran and Lucas-Lenard, 1997).
Under these conditions, the IFN-independent means of signaling
that is induced by peroxisomal MAVS may be particularly impor-
tant in controlling infection. Consistent with this idea, MAVS-Mito
cells were as susceptible to VSV infection as MAVS-KO or -Cyto
cells (Figure 6D), suggesting that in the absence of IFN produc-
tion, the mitochondrial signaling pathway is functionally defec-
tive. Most notably, MAVS-Pex cells were nearly as effective at
controlling VSV as MAVS-WT cells (Figure 6D). These results
suggest that MAVS signaling from peroxisomes is the primary
means of controlling viruses that interfere with IFN expression,
thus underscoring the importance of this organelle in host
defense.
Downstream Regulators of MAVS Signaling
from Peroxisomes
To identify downstream signaling regulators of peroxisomal
MAVS, we overexpressed each MAVS allele in 293T human
kidney epithelial cells. MAVS-WT, -Mimic, -Mito, and -Pex
each induced the activation of reporter genes controlled by
NF-kB and AP-1 (Figure 6E). In addition, an IRF1 reporter and
an ISRE that typically reports IRF3 activity were induced, sug-
gesting a role of these IRFs in MAVS signaling from peroxisomes
(Figure 6E). MAVS-Cyto did not activate any reporter. Within
these cells, we found that ISRE activation by either MAVS-WT
or MAVS-Pex was potentiated by overexpression of TRAF3
and inhibited by expression of a dominant negative allele of
TRAF6 (Figure S5A), suggesting the involvement of these known
RLR regulators in peroxisomal signaling (Saha et al., 2006; Yosh-
ida et al., 2008). In contrast, expression of a dominant-negative
allele of the antiviral factor FADD has a minimal affect on
MAVS signaling (Figure S5A), which is consistent with a recent
report (Balachandran et al., 2007). Notably, overexpression of
NLRX1, a negative regulator that is uniquely located on mito-
chondria (Figure S5B) (Moore et al., 2008) did not interfere with
MAVS-Pex signaling, but did inhibit signaling by MAVS-WT
(Figure S5A).
To confirm the roles of IRF1 and IRF3 in peroxisomal signaling,
we enlisted VSV to study the IFN-independent means of ISG
expression, since only the peroxisomal pathway functions to
control replication of this virus, although some ISGs wereRole for Peroxisomal and Mitochondrial MAVS in Antiviral Gene
with reovirus for 3, 9, or 16 hr was subject to microarray analysis. The similarity
is displayed as Pearson correlation coefficient-based heat map. Samples are
nfection, MAVS-Pex cells display a gene expression pattern that is most similar
lated genes depicted in a log-log scale scatter plot. Each data point indicates
ell lines and during all time points upon reovirus infection.
ch heat map. See also Figure S4.
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Figure 6. Peroxisomal MAVS Elicits a Functional
Antiviral Response
(A) MAVS-expressing MEFs and MAVS-KO MEFs were
infected with reovirus at an MOI of 3. At the indicated
times, virus titers were determined by plaque assay.
(B) MAVS-WT, -Mimic-expressing cells and MAVS-KO
MEFs were infected with VSV at an MOI of 3. After 8 hr,
RNA was isolated and analyzed for ISG and type I IFN
expression with nCounter.
(C) Same as (B) except MAVS-Pex, MAVS-Mito, and
MAVS-Cyto MEFs were analyzed.
(D) MAVS-expressing MEFs and parental MAVS-KO cells
were infected with VSV at an MOI of 0.01. At the indicated
times, virus titers were determined by plaque assay.
(E) 293T cells were transiently transfected with an ISRE,
IRF1, NF-kB, or AP1 luciferase reporters together with
empty pMSCV vector (control) or MAVS (WT, Mimic,
Pex, Mito, or Cyto). Results were normalized to Renilla
luciferase activity and are shown as fold increase relative
to cells transfected with empty vector. Error bars show
standard deviation of triplicate transfections.
See also Figure S5.induced by VSV in cells expressing MAVS-Mito (Figure 6C).
MEFs derived from various IRF-KO mice were infected with
VSV and assessed for their ability to induce ISGs. Whereas WT
cells induced the expression of several ISGs (and no IFNs), cells
lacking IRF1 or IRF3 were incapable of inducing ISG expression
(Figures 7A and 7B). A few ISGs (e.g., OAS1g) also required
another family member, IRF5. These data indicate that IRF1676 Cell 141, 668–681, May 14, 2010 ª2010 Elsevier Inc.and IRF3 are central regulators of IFN-indepen-
dent ISG expression and may act downstream
of peroxisomal MAVS.
Cell Type-Specific Actions of
Peroxisomal and Mitochondrial MAVS
The prototypical innate-immune adaptor MyD88
regulates TLR signaling and induces different
transcriptional responses in different cell types.
Whether other adaptor proteins also display
this diversity of responses is unclear. To
address this for MAVS, we examined the func-
tion of peroxisomal and mitochondrial MAVS in
macrophages. Each MAVS allele was ex-
pressed in immortalized bone marrow-derived
macrophages isolated from MAVS-KO mice.
The localization of each MAVS protein was
similar to that observed in MEFs (compare
Figures S2 and S5C). In response to reovirus
infection, macrophages that contained mito-
chondrial MAVS (MAVS-WT or -Mito) induced
transcripts encoding IFNs (Figure 7C) and ISGs
(Figure S5D). MAVS-Cyto was unable to induce
gene expression in response to reovirus infec-
tion. Unlike MEFs, reovirus-infected macro-
phages expressed inflammatory cytokines
such as IL-1b (Figure 7D), IL-6, IL-12b, and
TNFa (Figure S5D and data not shown). Another
difference between MEFs and macrophageswas that MAVS-Mito-expressing macrophages exhibited no
kinetic delay in reovirus-induced gene expression. These results
suggest that like the TLR adaptor MyD88, the function of MAVS
is controlled in a cell type-specific way.
Peroxisomal MAVS induced the expression of some genes to
the same levels observed with the WT allele, such as A20, IL-1b,
Cox2, CXCL2 (MIP-2a), CCL4 (MIP-1b), and Fos (Figure 7D),
whereas others were induced more than 3-fold but still less than
in WT cells, e.g., viperin, IFIT1, and IFIT2 (Figure S5D). Of note,
peroxisomal MAVS was unable to induce the expression of any
IFN gene in macrophages (Figure 7C). Thus, despite cell type-
specific activities of MAVS, a fundamental feature of the RLR
signaling network appears to be that peroxisomal MAVS func-
tions to promote an IFN-independent means of gene expression.DISCUSSION
The best-characterized sensors of cytosolic viruses are mem-
bers of the RLR family, which enlist the adaptor protein MAVS
to initiate antiviral signaling (Kawai and Akira, 2007). MAVS is
one of a growing group of tail-anchored membrane proteins,
which contain a C-terminal transmembrane domain (Gandre-
Babbe and van der Bliek, 2008; Koch et al., 2005; Seth et al.,
2005). This anchor was originally reported to promote MAVS
recruitment to the mitochondrial outer membrane, providing a
landmark of where RLR signaling can occur (Seth et al., 2005).
This discovery established that cytosolic detection systems,
like extracellular detection systems (e.g., TLRs), use membranes
as scaffolds for signal transduction. In the TLR network, however,
signaling occurs from a variety of different organelles, not just
one (Barton and Kagan, 2009). We report here that in addition
to mitochondria, the antiviral signaling protein MAVS is located
on peroxisomes in several human and murine cell types.
The central finding of this study—that peroxisomes are a site of
signal transduction—was established with a complementary set
of assays that measured (1) messenger RNAs (mRNAs) encoding
ISGs and IFNs, (2) protein levels of ISGs and IFNs, (3) the induc-
tion of a functional antiviral state in cells, and (4) infection-
induced changes in peroxisome morphology. In each of these
assays, we found that peroxisomes are a site of MAVS-depen-
dent signaling. Moreover, we obtained these results by using
several unrelated RNA viruses as physiological triggers of RLR
signaling, which suggests that peroxisomal signaling is a funda-
mental component of the RLR network.
The RLR signaling network now joins the TLRs as pattern
recognition systems that signal from multiple organelles. Both
systems require that a transmembrane protein be positioned
on specific organelles—the receptors themselves in the case
of TLRs and the MAVS adaptor in the case of RLRs (Akira
et al., 2006; Barton and Kagan, 2009). Interestingly, when
considering these two networks, the function of diversifying
signaling locale appears to be distinct. In the case of TLRs, differ-
ential receptor placement diversifies the types of pathogens that
can be detected: TLRs found on endosomes recognize viruses,
while TLRs found on the plasma membrane typically recognize
bacteria. In contrast, differential MAVS placement does not
diversify the types of viruses detected by RLRs, but diversifies
the types of signaling pathways that are activated. In the case
of reovirus and influenza virus infection of fibroblasts, peroxi-
somal MAVS triggers the rapid expression of ISGs, whereas
mitochondrial MAVS triggers delayed ISG and IFN expression.
This diversification is functionally important, as our data indicate
that MAVS signaling must occur from both organelles to limit
reovirus replication.Our studies revealed another important similarity between
the RLR and TLR networks, that of cell type-specific functions
for adaptor proteins. In fibroblasts, MAVS functioned to induce
expression of IFNs and ISGs, but not inflammatory cytokines.
In contrast, IFNs, ISGs, and cytokines were all induced by
MAVS signaling in macrophages. Thus, MAVS can be grouped
with the TLR adaptor MyD88 as immune regulators that induce
cell type-specific transcriptional responses. What is the benefit
of cell type-specific actions of innate immune signaling path-
ways? One benefit may lie in the primary functions of the cells
responding to a given virus. For example, macrophages are
dedicated sentinels of the innate immune system. As such,
within these cells, infection triggers MAVS-dependent inflamma-
tory cytokine production and antiviral factors. Fibroblasts, in
contrast, are tissue-resident cells that are primarily involved in
organ homeostasis—a condition that is disrupted under inflam-
matory conditions. Thus, designing MAVS to induce antiviral
factors but not inflammatory cytokines in fibroblasts may aid
these cells in maintaining homeostasis under infectious condi-
tions. We speculate that the diversification of adaptor functions
in innate immunity may be a general mechanism to tailor signal-
ing pathways to the needs of functionally diverse cell types.
Our finding that peroxisomal localization of MAVS is required
for rapid but transient induction of antiviral ISGs whereas mito-
chondrial MAVS promotes ISG expression with delayed kinetics
in fibroblasts is especially intriguing. The kinetic differences of
ISG expression were explained by the observation that peroxi-
somal MAVS induced a cell-intrinsic means of ISG induction,
which occurred in the absence of detectable IFN expression.
Mitochondrial MAVS induced cell-intrinsic ISG expression as
well, but maximal induction occurred through the actions of
secreted IFNs. Our studies did not reveal an obvious difference
in the downstream regulators activated by peroxisomal versus
mitochondrial MAVS, but the studies performed in 293T cells
suggest that the selective positioning of negative regulators
(e.g., NLRX1) may contribute to organelle-specific responses.
Future work will be required to address this point.
The functional importance of RLR signaling from peroxi-
somes was best revealed by experiments with VSV, which
interferes with IFN expression and renders the mitochondrial
pathway ineffective. As a result, even though MAVS is present
on mitochondria and peroxisomes in WT cells, a functional anti-
viral response against VSV is only induced by the peroxisomal
pathway. We also exploited VSV infection to dissect the perox-
isomal signaling pathway using cells derived from genetically-
deficient mice. While we found that IRF3 plays a role in ISG
expression, this factor is also involved in the regulation of IFN
expression (Sato et al., 2000) and may therefore be considered
a more general regulator of antiviral gene expression. Indeed
IRF3 is also involved in IFN expression induced by non-RLRs
(Kawai and Akira, 2007). IRF1, on the other hand, is needed
for expression of all ISGs that we examined in VSV-infected
cells and is not required for IFN expression (Tamura et al.,
2008). IRF1 may thus uniquely control IFN-independent
signaling events that lead to ISG expression and antiviral immu-
nity. Our experiments with VSV also revealed a probable benefit
of utilizing both IFN-dependent and IFN- independent mecha-
nisms of ISG induction: for pathogens that disrupt theCell 141, 668–681, May 14, 2010 ª2010 Elsevier Inc. 677
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expression of IFNs, the peroxisomal pathway retains the ability
to induce ISGs and create a functional, albeit temporary, anti-
viral state.
In fibroblasts, the cooperative actions of MAVS on peroxi-
somes and mitochondria are needed for maximal antiviral immu-
nity, and signaling from each organelle occurs independently of
the other. As such, it appears that a simple mathematical equa-
tion can be proposed to explain antiviral signal transduction:
RLR = Pex + Mito (Figure 7E). If either term in this equation is
removed, then the RLR signaling network operates inefficiently,
and antiviral immunity is compromised. We note however, that
maximal ISG and IFN expression requires signaling from both
organelles, which likely indicates that crosstalk exists to allow
the two pathways to be properly integrated.
In closing, our studies establish a new function for peroxi-
somes, that of a subcellular compartment that promotes a rapid
response to viral infection. We speculate that additional organ-
elles may harbor pathogen detection systems, and our work pro-
vides a mandate to expand the search for these organelles.
EXPERIMENTAL PROCEDURES
Plasmids and Antibodies
pCMV2 Flag-IPS-1, pEF-HA-MAVS, pCDNA3-HA-NLRX1, and the myc-Mff
plasmid were gifts from S. Akira, Z. Chen, J.Ting, and A. van der Bliek,
respectively. The plasmids Dsred-PTS1, bicistronic Pex19 / EGFP-PTS1,
Pex19, EGFP-Pex19, Pex13p-EGFP, and pCMV-TIRAP-flag have been
described (Fransen et al., 2001; Horng et al., 2001; Vastiau et al., 2006).
Pex19 was amplified from EGFP-Pex19 and inserted into the retroviral vector
pMSCV IRES GFP. All MAVS constructs are based on the allele BC044952.
The full-length (1–540) and a truncated (1–500) sequence were amplified from
pEF-HA-MAVS by PCR. For chimeric MAVS alleles, the C-terminal 40 resi-
dues were replaced by the following sequences: PEX13 (NM_002618) resi-
dues 136–233, FIS1 (NM_016068) residues 127–152, and Omp25
(NM_022599) residues 109–145 by overlap extension PCR and cloned into
pMSCV IRES GFP.
Anti-Pex19 and anti-Pex14, anti-viperin, and anti-myc 9E10 were gifts from
M. Fransen, P. Cresswell, and S. Hansen, respectively. Anti-MAVS (Bethyl
Laboratories), anti-mtHSP70 (ABR Affinity Reagents), anti-Flag M2 (Sigma),
anti-Fis (Santa Cruz), anti-HA (Roche), and anti-b-actin (Sigma) were used
according to the manufacturers’ recommendations.
Cell Lines, Retroviral Gene Transfer, and Cell Fractionation
MEFs, Huh-7, 293T, Vero, and MDCK cells were cultured according to stan-
dard techniques. MAVS-KO MEFs, PEX19-deficient human skin fibroblasts,
and L929 cells stably expressing an ISRE-luciferase reporter were provided
by Z. Chen, R. Wanders, and B. Beutler, respectively. MEFs lacking IRF1, 3,
and 5 were provided by K. Fitzgerald. MAVS and PEX19 alleles were intro-
duced in MAVS-KO MEFs and Pex19-deficient human skin fibroblasts by
retroviral gene transfer and then sorted for equal GFP fluorescence to
normalize MAVS expression levels. Fractionations of HepG2 cells were per-
formed as described (Fransen et al., 2004).Figure 7. Transcription Factors that Control Peroxisomal MAVS Signa
(A and B) WT, IRF1, IRF3, and IRF5 KO MEFs were infected with VSV at an MOI of
with nCounter.
(C and D) Immortalized MAVS-KO macrophages were retrovirally transduced with
cell population was determined to be 20%–30% as assessed by fluorescence mic
harvested, and RNA was analyzed for expression of type I IFN (C) and other infla
(E) Model of organelle specific MAVS signaling in fibroblasts. Peroxisomal MAVS
chondrial MAVS induces ISGs with delayed kinetics and primarily dependent on
transient antiviral effects, while mitochondrial MAVS promotes a sustained respoDNA Transfections and Immunofluorescence
MEFs and Huh-7 cells were transfected with Fugene-6 (Roche) for 24 hr at
37C. Where indicated, cells were incubated with 250 nM MitoTracker Deep
Red FM (Molecular Probes) for 30 min at 37C prior to fixation. For NLRX1 visu-
alization, Huh-7 cells expressing HA-NLRX1 were incubated with 160 nM
MitoTracker for 20 min at 37C and permeabilized with 0.1% saponin in
80 mM PIPES, 5 mM EGTA, and 1 mM MgCl2 (pH 6.8) for 10 min at 25
C. Cells
were fixed with 2% paraformaldehyde for 20 min at 25C and permeabilized
for 10 min with 0.1% Triton X-100. Samples were treated with block buffer
(2% goat serum and 50 mM ammonium chloride in PBS) for 30 min, and the
appropriate antibodies were diluted in block buffer. Antibody binding was
detected using antibodies conjugated with Alexa fluor 488, 594, or 647 (Molec-
ular Probes). Samples were imaged on a Nikon TE-2000 inverted microscope
fitted with a video-rate confocal system consisting of a spinning disk confocal
head (Yokogawa). Using a 1003 oil immersion objective with a numerical aper-
ture of 1.4, confocal images were collected as a 3D stack with a focal step size
of 0.27 mm. Micrographs were processed with Adobe Photoshop.
Virus Stocks, Infections, and Plaque Assay
Reovirus Type 3 Dearing (Cashdollar lab clone) was propagated on L929 cells
and plaque purified as described (Furlong et al., 1988). Cells were seeded
12–16 hr prior to infection on 6-well plates. On the day of infection, medium
was replaced by addition of 2 ml fresh medium containing virions at a multi-
plicity of infection (MOI) of 100, unless stated otherwise. Where indicated, cells
were preincubated with 20 mg/ml brefeldin A (Invitrogen) and infections were
carried out in the presence of the drug. Type I IFN activity was blocked by addi-
tion of 250 neutralizing units/ml anti-IFNb and 500 neutralizing units/ml anti-
IFNa (PBL InterferonSource) antibodies at the time of infection. So that
reovirus replication could be assessed, purified virions were diluted in 100 ml
attachment buffer (phosphate-buffered saline with 2 mM MgCl2) and incu-
bated with cell monolayers for 1 hr at room temperature. After removal of unab-
sorbed virus by two washes with attachment buffer, cells were incubated for
the indicated times. Next, cells were lysed by freeze/thaw and infectious titers
were measured by serial dilution onto L929 cells as described (Middleton et al.,
2007).
Influenza virus (A/Puerto Rico/8/34, H1N1) lacking the NS1 gene was prop-
agated in Vero cells as described (Garcı´a-Sastre et al., 1998) and titrated by
plaque assay on MDCK cells. For infection, cell monolayers were incubated
with DNS1 virus at a MOI of 5 for 1 hr at 37C in Dulbecco’s modified Eagle’s
medium supplemented with 0.3% bovine serum albumin, washed, and incu-
bated with growth media.
VSV (Indiana) infections were performed as described (Cureton et al., 2009),
and viral titer was determined by plaque assay on Vero cells.
Immunoblotting and Type I IFN Bioassay
Protein extracts were prepared by standard techniques, and 40 mg cell extract
was separated by SDS-PAGE and analyzed by immunoblot. Type I IFN activity
was measured as described (Jiang et al., 2005).
Gene Arrays and Bioinformatics
Cells were infected as described above, and RNA was purified with QIAShred-
der and the RNeasy Mini Kit (QIAGEN). Microarrays were performed by the
Molecular Genetics Core Facility at Children’s Hospital Boston supported by
NIH-P50-NS40828 and NIH-P30-HD18655. Quantile normalization was used
for signal extraction and normalization. Two criteria were applied to identifyling
3. After 8 hr, RNA was isolated and analyzed for ISG and type I IFN expression
MAVS-WT, -Pex, -Mito, and-Cyto for 48 hr. The transduction efficiency of each
roscopy. Cells were infected with reovirus and at the indicated times and were
mmatory genes (D) with nCounter. See also Figure S5.
is essential for rapid ISG expression independent of type I IFN, whereas mito-
type I IFN secretion. Therefore, peroxisomal MAVS mediates immediate and
nse later during infection. See also Figure S5.
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differentially regulated genes: (1) statistical significance of p < 0.05 and (2) fold
change of greater than 2 (ratio > 2.0 or < 0.5). Four thousand eighty-nine genes
passed both criteria for at least one of the assayed conditions. Samples are
clustered based on the Pearson’s correlation coefficient for the profile of those
4089 genes. The Pearson correlation, hierarchical clustering, and heat map
were generated with the R functions ‘‘cor,’’ ‘‘hclust,’’ and ‘‘heatmap,’’ respec-
tively. Signal intensity that reflected mRNA expression was presented on heat
maps or scatterplots on a log scale according to a color-coded intensity scale
with R software (The R Project for Statistical Computing). Each data point in the
scatterplots presented indicates a gene whose expression level exhibited
a change >2-fold.
mRNA Detection and Analysis with nCounter
nCounter CodeSets were constructed to detect genes selected by the Gene-
Selector algorithm and additional controls as described. Two hundred and
forty thousand cells were lysed in RLT buffer (QIAGEN) supplemented with
b-mercaptoethanol. Five percent of the lysate was hybridized for 16 hr with
the CodeSet and loaded onto the nCounter prep station, followed by quantifi-
cation with the nCounter Digital Analyzer. To allow for side-by-side compari-
sons of nCounter experiments, we normalized the nCounter data in two steps.
We first controlled for small variations in the efficiency of processing by
normalizing measurements from all samples analyzed on a given run to the
levels of chosen positive controls provided by the nCounter instrument.
Second, we normalized the data obtained for each sample to the expression
of nine control genes (Gapdh, Ik, Mea1, Ndufs5, Ndufa7, Rbm6, Shfm1,
Tomm7, and Ywhaz). These genes were described to be unchanged in cells
exposed to a variety of infectious conditions (Amit et al., 2009). For every
sample, we computed the weighted average of the mRNA counts of the nine
control transcripts and normalized the sample’s values by multiplying each
transcript count by the weighted average of the controls.ACCESSION NUMBERS
The microarray data discussed in this publication are accessible through
GEO Series accession number GSE21215 (http://www.ncbi.nlm.nih.gov/
geo/query/acc.cgi?acc=GSE21215).SUPPLEMENTAL INFORMATION
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